Covid-19: Germans advance on vaccine and treatment

The results of phase 1 of the vaccine candidate developed by the German biotech CureVac showed an immune response in humans. At the same time, a treatment developed by other German researchers has made it possible to limit the replication of the coronavirus in vitro. 

Source:https://www.pourquoidocteur.fr/Articles/Question-d-actu/34331-Covid-19-Allemands-avancent-vaccin-un-traitement